References
Chen X, Yuan Y, Shen K, et al. Accuracy of estrogen receptor, progesterone receptor, and HER2 status between core needle and open excision biopsy in breast cancer: a meta-analysis. Breast Cancer Res Treat. 2012;134:957–67.
Fujii T, Kogawa T, Dong W, et al. Revisiting the definition of estrogen receptor positivity in HER2-negative primary breast cancer. Ann Oncol. 2017;28:2420–8.
Zhu S, Chen X, Shen K, et al. Clinicopathological features and disease outcome in breast cancer patients with hormonal receptor discordance between core needle biopsy and following surgical sample. Ann Surg Oncol. 2019;26:2779–86.
Sherman RE, Anderson SA, Dal Pan GJ, et al. Real-world evidence: what is it and what can it tell us? N Engl J Med. 2016;375:2293–7.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Disclosure
There are no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
ASO Author Reflections offer a brief invited commentary on the article, "Clinicopathological Features and Disease Outcome in Breast Cancer Patients With Hormonal Receptor Discordance Between Core Needle Biopsy and Following Surgical Sample." Ann Surg Oncol. 2019;26:2779–86.
Rights and permissions
About this article
Cite this article
Zhu, S., Chen, X. & Shen, K. ASO Author Reflections: Core Needle Biopsy and Hormonal Receptor Retesting in Breast Cancer: Controversy and Management. Ann Surg Oncol 27 (Suppl 3), 731–732 (2020). https://doi.org/10.1245/s10434-019-07961-0
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-019-07961-0